Torii Pharmaceutical Co Ltd
TSE:4551
Torii Pharmaceutical Co Ltd
TSE:4551
Price:
4 695
JPY
-0.74%
Market Cap:
135.2B
JPY
Balance Sheet
Balance Sheet Decomposition
Torii Pharmaceutical Co Ltd
Torii Pharmaceutical Co Ltd
| Current Assets | 94.6B |
| Cash & Short-Term Investments | 43.3B |
| Receivables | 31.1B |
| Other Current Assets | 20.3B |
| Non-Current Assets | 46B |
| Long-Term Investments | 33.2B |
| PP&E | 2.5B |
| Intangibles | 321m |
| Other Non-Current Assets | 10.1B |
Balance Sheet
Torii Pharmaceutical Co Ltd
Torii Pharmaceutical Co Ltd
Currency: JPY
Millions
Annual
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
14 361
|
22 393
|
6 458
|
3 484
|
5 773
|
3 717
|
4 012
|
9 203
|
5 004
|
3 319
|
|
| Cash Equivalents |
14 361
|
22 393
|
6 458
|
3 484
|
5 773
|
3 717
|
4 012
|
9 203
|
5 004
|
3 319
|
|
| Short-Term Investments |
18 708
|
11 102
|
24 957
|
28 606
|
33 150
|
38 528
|
38 198
|
38 489
|
38 999
|
39 979
|
|
| Total Receivables |
27 904
|
26 560
|
29 122
|
27 137
|
25 150
|
18 955
|
22 010
|
22 865
|
28 502
|
31 068
|
|
| Accounts Receivables |
27 897
|
26 553
|
29 108
|
27 137
|
25 136
|
18 948
|
22 010
|
22 865
|
28 488
|
31 061
|
|
| Other Receivables |
7
|
7
|
14
|
0
|
14
|
7
|
0
|
0
|
14
|
7
|
|
| Inventory |
9 835
|
10 606
|
10 125
|
8 313
|
7 513
|
7 151
|
8 763
|
8 969
|
10 742
|
14 217
|
|
| Other Current Assets |
6 347
|
9 462
|
13 318
|
10 913
|
38 431
|
28 391
|
24 309
|
12 077
|
4 901
|
6 057
|
|
| Total Current Assets |
77 155
|
80 123
|
83 980
|
78 453
|
110 017
|
96 742
|
97 292
|
91 603
|
88 148
|
94 640
|
|
| PP&E Net |
6 182
|
5 752
|
5 540
|
3 431
|
2 778
|
1 777
|
2 078
|
2 282
|
2 095
|
2 451
|
|
| PP&E Gross |
6 182
|
5 752
|
5 540
|
3 431
|
2 778
|
1 777
|
2 078
|
2 282
|
2 095
|
2 451
|
|
| Accumulated Depreciation |
18 245
|
18 959
|
19 541
|
19 592
|
19 295
|
4 263
|
4 343
|
4 591
|
4 851
|
5 020
|
|
| Intangible Assets |
955
|
896
|
817
|
669
|
526
|
442
|
512
|
517
|
429
|
321
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
6 800
|
3 877
|
7 478
|
13 770
|
19 764
|
20 810
|
22 309
|
30 282
|
33 970
|
33 197
|
|
| Other Long-Term Assets |
7 776
|
7 877
|
6 926
|
6 930
|
6 858
|
6 255
|
8 619
|
9 005
|
8 790
|
10 055
|
|
| Total Assets |
98 868
N/A
|
98 525
0%
|
104 741
+6%
|
103 253
-1%
|
139 943
+36%
|
126 026
-10%
|
130 810
+4%
|
133 689
+2%
|
133 432
0%
|
140 664
+5%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
6 853
|
6 698
|
8 242
|
6 657
|
5 752
|
5 143
|
5 793
|
6 584
|
6 981
|
10 448
|
|
| Accrued Liabilities |
1 370
|
1 376
|
1 482
|
1 495
|
828
|
689
|
812
|
753
|
931
|
967
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
342
|
199
|
85
|
85
|
85
|
85
|
211
|
283
|
222
|
148
|
|
| Other Current Liabilities |
5 907
|
5 037
|
6 059
|
6 037
|
18 277
|
3 544
|
5 556
|
5 601
|
4 370
|
6 590
|
|
| Total Current Liabilities |
14 472
|
13 310
|
15 868
|
14 274
|
24 942
|
9 461
|
12 372
|
13 221
|
12 504
|
18 153
|
|
| Long-Term Debt |
725
|
571
|
465
|
380
|
294
|
209
|
275
|
241
|
22
|
281
|
|
| Other Liabilities |
845
|
1 088
|
1 289
|
1 507
|
1 582
|
1 265
|
1 148
|
1 003
|
772
|
697
|
|
| Total Liabilities |
16 042
N/A
|
14 969
-7%
|
17 622
+18%
|
16 161
-8%
|
26 818
+66%
|
10 935
-59%
|
13 795
+26%
|
14 465
+5%
|
13 298
-8%
|
19 131
+44%
|
|
| Equity | |||||||||||
| Common Stock |
5 190
|
5 190
|
5 190
|
5 190
|
5 190
|
5 190
|
5 190
|
5 190
|
5 190
|
5 190
|
|
| Retained Earnings |
71 384
|
72 870
|
76 247
|
76 067
|
102 087
|
104 234
|
106 250
|
108 846
|
109 425
|
110 813
|
|
| Additional Paid In Capital |
6 416
|
6 416
|
6 416
|
6 426
|
6 429
|
6 437
|
6 445
|
6 453
|
6 460
|
6 473
|
|
| Unrealized Security Profit/Loss |
698
|
558
|
745
|
864
|
850
|
636
|
523
|
117
|
427
|
414
|
|
| Treasury Stock |
863
|
1 478
|
1 480
|
1 455
|
1 431
|
1 407
|
1 393
|
1 381
|
1 369
|
1 358
|
|
| Other Equity |
1
|
0
|
1
|
0
|
0
|
1
|
0
|
1
|
1
|
1
|
|
| Total Equity |
82 826
N/A
|
83 556
+1%
|
87 119
+4%
|
87 092
0%
|
113 125
+30%
|
115 091
+2%
|
117 015
+2%
|
119 224
+2%
|
120 134
+1%
|
121 533
+1%
|
|
| Total Liabilities & Equity |
98 868
N/A
|
98 525
0%
|
104 741
+6%
|
103 253
-1%
|
139 943
+36%
|
126 026
-10%
|
130 810
+4%
|
133 689
+2%
|
133 432
0%
|
140 664
+5%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
28
|
28
|
28
|
28
|
28
|
28
|
28
|
28
|
28
|
28
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
